Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;13(12):1307-1316.
doi: 10.1016/j.jalz.2017.04.011. Epub 2017 Jun 15.

Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study

Affiliations

Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study

Paul K Crane et al. Alzheimers Dement. 2017 Dec.

Abstract

Introduction: There may be biologically relevant heterogeneity within typical late-onset Alzheimer's dementia.

Methods: We analyzed cognitive data from people with incident late-onset Alzheimer's dementia from a prospective cohort study. We determined individual averages across memory, visuospatial functioning, language, and executive functioning. We identified domains with substantial impairments relative to that average. We compared demographic, neuropathology, and genetic findings across groups defined by relative impairments.

Results: During 32,286 person-years of follow-up, 869 people developed Alzheimer's dementia. There were 393 (48%) with no domain with substantial relative impairments. Some participants had isolated relative impairments in memory (148, 18%), visuospatial functioning (117, 14%), language (71, 9%), and executive functioning (66, 8%). The group with isolated relative memory impairments had higher proportions with ≥ APOE ε4 allele, more extensive Alzheimer's-related neuropathology, and higher proportions with other Alzheimer's dementia genetic risk variants.

Discussion: A cognitive subgrouping strategy may identify biologically distinct subsets of people with Alzheimer's dementia.

Keywords: Alzheimer's disease; Cognition; Endophenotypes; Genetics; Heterogeneity; Neuropathology; Subgroups.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Derivation of the analytic sample.

References

    1. Gotovac K, Hajnsek S, Pasic MB, Pivac N, Borovecki F. Personalized medicine in neurodegenerative diseases: how far away? Mol Diagn Ther. 2014;18(1):17–24. - PubMed
    1. Kosik KS. Personalized medicine for effective Alzheimer disease treatment. JAMA Neurol. 2015;72(5):497–498. - PubMed
    1. Cholerton B, Larson EB, Quinn JF, et al. Precision Medicine: Clarity for the Complexity of Dementia. Am J Pathol. 2016;186(3):500–506. - PMC - PubMed
    1. Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–629. - PubMed
    1. Lezak MD. Neuropsychological assessment. 3. NY: Oxford University Press; 1995.

MeSH terms

Substances